A novel method in preparation of acellularporcine corneal stroma tissue for lamellar keratoplasty.

Yi Shao, Jing Tang, Yueping Zhou, Yangluowa Qu, Hui He, Qiuping Liu, Gang Tan, Wei Li, Zuguo LiuPubMed 2015

TL;DR

This paper introduces a novel, efficient method for preparing acellular porcine corneal stroma (ACSDs) using human serum and electrophoresis. This technique successfully removes cells and the immunogenic α-Gal epitope, resulting in a biomaterial that is optically, biomechanically, and histologically similar to native corneal tissue, showing promising results for lamellar keratoplasty in rabbits.

What Problem Does This Paper Address?

Corneal blindness is a significant global health issue, and while corneal transplantation is the primary treatment, a severe shortage of donor tissue, particularly in Asian countries, limits its application. This scarcity drives the need for viable corneal substitutes. Porcine corneas are an attractive alternative due to their structural similarity to human corneas, but xenotransplantation faces a major hurdle: hyperacute rejection mediated by the α-Gal epitope present on porcine cells. Existing decellularization methods often require lengthy procedures or harsh chemicals, and their effectiveness in removing α-Gal epitopes hasn't been consistently evaluated. This paper aims to address these limitations by developing a more efficient and effective method for creating acellular porcine corneal tissue that minimizes immunogenicity for potential clinical use.

Methods

The researchers developed a novel decellularization protocol involving two key steps:

  1. Incubation with Human Serum: De-epithelized fresh porcine corneas (DFPCs) were incubated in 100% fresh human serum at 37°C for up to 24 hours. This step was hypothesized to initiate cell removal through apoptosis.
  2. Electrophoresis: Following serum incubation, the corneas underwent electrophoresis at 4°C for 1 hour in a buffered solution. This was intended to further remove cellular remnants and residual DNA.

The resulting acellular porcine corneal stroma discs (ACSDs) were then characterized for:

  • Cellular Removal: DAPI and H&E staining to visualize nuclei.
  • DNA Content: DNA fragmentation assays.
  • Immunogenicity: α-Gal epitope detection using Griffonia simplicifolia I lectin B4 (GSIB4) staining.
  • Physical and Biomechanical Properties: Light transparency, water content, expansion, and tensile strength.
  • Ultrastructure: Transmission electron microscopy (TEM).
  • Histocompatibility: In vivo implantation into rabbit corneal stromal pockets and anterior chambers.
  • Efficacy in Lamellar Keratoplasty (LKP): Transplantation into rabbit corneal defects, followed by slit-lamp microscopy, in vivo confocal microscopy, and histological examination.

Datasets

The study utilized porcine eyes as the source material for corneal tissue. No specific datasets in the computational sense were used for training or evaluation; rather, the research involved experimental procedures on biological tissues and in vivo animal models.

Key Insights and Ideas

  • Human Serum as a Decellularizing Agent: The study highlights the effectiveness of human serum, in combination with electrophoresis, as a relatively mild yet potent agent for decellularizing porcine corneal stroma.
  • Apoptosis as the Primary Mechanism: The research suggests that human serum induces apoptosis in porcine corneal stromal cells, particularly in the anterior stroma, as the primary mechanism for decellularization.
  • Targeted α-Gal Epitope Removal: A crucial finding is that this method effectively removes the immunogenic α-Gal epitope from the anterior stroma, which is a major barrier to xenotransplantation.
  • Preservation of Corneal Structure and Function: The resulting ACSDs retained similar optical, biomechanical, and ultrastructural properties to native porcine corneas, indicating that the decellularization process did not significantly degrade the tissue's integrity.
  • Promising Xenotransplantation Potential: In vivo studies in rabbits demonstrated excellent biocompatibility, with ACSDs showing no rejection, high transparency, and good integration without excessive inflammation or neovascularization, suggesting their suitability for LKP.

Key Results

  • Efficient Decellularization: Incubation with human serum for 24 hours, followed by electrophoresis, significantly reduced cellular nuclei in the anterior porcine corneal stroma.
  • DNA Removal: Electrophoresis further ensured the removal of residual DNA, making it undetectable.
  • α-Gal Epitope Elimination: GSIB4 staining confirmed the near-complete removal of α-Gal epitopes from the anterior stroma after the treatment.
  • Biomechanical and Optical Similarity: ACSDs exhibited comparable light transparency, water content, expansion, and tensile strength to native porcine corneal tissue.
  • In Vivo Biocompatibility: ACSDs implanted in rabbit corneal stromal pockets remained transparent and showed minimal inflammatory cell infiltration.
  • Successful LKP in Rabbits: Rabbit lamellar keratoplasty using ACSDs resulted in high transparency and no signs of rejection or significant neovascularization at two months post-surgery, outperforming grafts made from DFPCs.
  • Tissue Remodeling: In vivo confocal microscopy and immunostaining showed evidence of stromal cell repopulation and organized tissue remodeling in ACSD grafts without excessive scarring or inflammation.

Limitations and Future Work

  • Heterogeneity of Keratocytes: The study suggests potential heterogeneity in keratocyte behavior and α-Gal epitope expression across different corneal layers, which warrants further investigation.
  • Long-Term Efficacy: While promising, the study focused on a two-month follow-up. Longer-term studies are needed to fully assess the remodeling and integration of ACSDs.
  • Clinical Translation: The authors acknowledge that further studies are necessary to clarify the origin of repopulating cells and to evaluate the long-term nerve recovery and efficacy in larger animal models (e.g., Macaca rhesus) before clinical application.
  • Purified Anti-Gal Antibodies: The discussion mentions the potential use of purified anti-Gal antibodies, suggesting a possible avenue for further refinement of the process.
  • Scalability: While the method is described as simple, further work may be needed to optimize it for large-scale production.

Summary updated

Abstract

Our objective was to develop a novel lamellar cornealbiomaterial for corneal reconstruction.Theporcine acellular corneal stroma discs (ACSDs) were prepared from de-epithelized fresh porcine corneas (DFPCs) by incubation with 100% fresh human serum and additional electrophoresis at 4°C. Such manipulation removed theanterior corneal stromal cells without residual of DNA content and α-Galantigen. Human serum decellularizing activity on porcineanterior corneal stroma cells is through apoptosis, and associated with the presence of α-Gal epitopes in anterior stroma. ACSDs displayed similar optical, biomechanical properties and ultrastructure to DFPCs, and showed good histocompatibility in rabbit corneal stromal pockets and anterior chamber. Rabbit corneallamellar keratoplasty (LKP) using ACSDs showed no rejection and high transparency of cornea at 2 months after surgery. In vivo confocal laser scanning microscopy and immunostaining analysis showed complete re-epithelization and stromal cell in growth of ACSDs without inflammatory cell infiltration, new blood vessel ingrowth and excessive wound healing. In conclusion, this novel decellularization method may be valuable for preparation of xenogenic corneal tissue for clinical application, ACSDs resulted from this method may be served as a matrix equivalent for LKP in corneal xenotransplantation.
BibTeX
@inproceedings{shao2015novel,
  author = {Yi Shao and Jing Tang and Yueping Zhou and Yangluowa Qu and Hui He and Qiuping Liu and Gang Tan and Wei Li and Zuguo Liu},
  title = {{A novel method in preparation of acellularporcine corneal stroma tissue for lamellar keratoplasty.}},
  booktitle = {PubMed},
  year = {2015},
}
Figure